Cited by 1,184Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Open access

Douketis, James D., Spyropoulos, Alex C., Kaatz, Scott, Becker, Richard C., Caprini, Joseph A., Dunn, Andrew S., Garcia, David A., Jacobson, Alan, Jaffer, Amir K., Kong, David F., Schulman, Sam, Turpie, Alexander G.G., Hasselblad, Vic, Ortel, Thomas L.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1501035PMC PMC4931686

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive procedure. We hypothesized that forgoing bridging anticoagulation would be noninferior to bridging with low-molecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be superior to bridging with respect to major bleeding. METHODS: We performed a randomized, double-blind, placebo-controlled trial in which, after perioperative interruption of warfarin therapy, patients were randomly assigned to receive bridging anticoagulation therapy with low-molecular-weight heparin (100 IU of dalteparin per kilogram of body weight) or matching placebo administered subcutaneously twice daily, from 3 days before the procedure until 24 hours before the procedure and then for 5 to 10 days after the procedure. Warfarin treatment was stopped 5 days before the procedure and was resumed within 24 hours after the procedure. Follow-up of patients continued for 30 days after the procedure. The primary outcomes were arterial thromboembolism (stroke, systemic embolism, or transient ischemic attack) and major bleeding. RESULTS: In total, 1884 patients were enrolled, with 950 assigned to receive no bridging therapy and 934 assigned to receive bridging therapy. The incidence of arterial thromboembolism was 0.4% in the no-bridging group and 0.3% in the bridging group (risk difference, 0.1 percentage points; 95% confidence interval [CI], -0.6 to 0.8; P=0.01 for noninferiority). The incidence of major bleeding was 1.3% in the no-bridging group and 3.2% in the bridging group (relative risk, 0.41; 95% CI, 0.20 to 0.78; P=0.005 for superiority). CONCLUSIONS: In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was noninferior to perioperative bridging with low-molecular-weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding. (Funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health; BRIDGE ClinicalTrials.gov number, NCT00786474.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1501035

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Spencer, F. A., Mayr, M., Jaffer, A. K., Eckman, M. H., Dunn, A. S., & Kunz, R. (2012) · CHEST Journal · doi:10.1378/chest.11-2298 · Cited by 1,658
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · CHEST Journal · doi:10.1378/chest.08-0675 · Cited by 824
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 817
Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
Birnie, D. H., Healey, J. S., Wells, G. A., Verma, A., TANG, A. S. L., Krahn, A. D., Simpson, C. S., Paredes, F. A., Coutu, B., Leiria, T. L. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302946 · Cited by 589
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
Healey, J. S., Eikelboom, J. W., Douketis, J. D., Wallentin, L. C., Oldgren, J., Yang, S., Themeles, E., Heidbüchel, H., Avezum, Á., Reilly, P. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.090464 · Cited by 540

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 1

10.1016/S0025-6196(11)60891-4 · DOI

Sorted by citations

Items 601–700 of 1,000

ANTICOAGULANT AND ANTIPLATELET THERAPY OVER PERIOPERATIVE PERIOD
Тарасенко, С. О., Дубров, С. О., Suslov, G., & Мазніченко, В. А. (2021) · Pain anesthesia and intensive care · doi:10.25284/2519-2078.1(94).2021.230618 · Cited by 4
Management of patients after heart valve interventions. Expert opinion of the Working Group on Valvular Heart Diseases, Working Group on Cardiac Surgery, and Association of Cardiovascular Interventions of the Polish Cardiac Society
Płońska-Gościniak, E., Wojakowski, W., Kukulski, T., Gąsior, Z., Grygier, M., Mizia‐Stec, K., Hirnle, T., Olszowska, M., Tomkiewicz-Pająk, L., Kasprzak, J. D., et al. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0055 · Cited by 5
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation
Tseng, E. K., Crowther, M. A., & Hillis, C. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150867 · Cited by 4
Perioperative Anticoagulation Management
Zukowski, C. M., & Peak, J. (2018) · AORN Journal · doi:10.1002/aorn.12115 · Cited by 4
A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures
Marsh, K. L., Ahuja, T., Raco, V., Green, D., Sista, A. K., & Papadopoulos, J. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1740-0 · Cited by 4
Interruption and Reversal of Direct Oral Anticoagulants in Preprocedural and Acute Settings
Kulkarni, A., & Manek, M. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.05.180007 · Cited by 5
“The limited data available (from study of VKA based anticoagulation) suggest that the risk of bleeding complications associated with bridging anticoagulation are significant.(49) Given the relatively rapid onset and offset of anti-”
Background
Cost of incorrect application of antithrombotic prophylaxis prior to invasive procedures
Cuevas, M. V., Martínez-Sancho, I., Arribas, J., García-Díaz, C., & Cuevas, B. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4669-x · Cited by 4
Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
Kim, J., Park, K., Yu, I., Song, T., Kim, Y., Kim, B. J., Heo, S. H., Jung, J. ‐., Oh, K., Kim, C. K., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14175 · Cited by 4
“4%, where the proportion of previous stroke among included patients was 15–17% [3,4].”
Background
Influence of Perioperative Antithrombic Agent Discontinuation in Elective Posterior Spinal Surgery: A Propensity-Score-Matched Analysis
Okamoto, N., Kato, S., Doi, T., Nakamoto, H., Matsubayashi, Y., Taniguchi, Y., Inanami, H., Higashikawa, A., Kawamura, N., Hara, N., et al. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.10.182 · Cited by 4
Improving perioperative outcome
Chew, M. S., & Walder, B. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000577 · Cited by 4
Development of a nomogram for prediction of postoperative bleeding after transurethral resection of bladder tumors
Pellegrino, P., Scherer, T. P., Wettstein, M. S., Baumgartner, M., Eberli, D., Poyet, C., & Bieri, U. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04734-5 · Cited by 3
“Similarly, the necessity and management of preoperative bridging should be reassessed, especially in patients with a low-to-moderate risk of thromboembolic events [37–39].”
Comparing perioperative heparin bridging strategies in mechanical heart valve patients undergoing surgery: A systematic review and Bayesian meta-analysis
Batista, P. K. A., Montenegro, M. V., Gaelzer, G. C., Molinari, M. E., Malik, M., Silva, R. R. A. D. S., de Lucena, L. A., Bacca, C. D. O. F., & Giorgi, J. M. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109735 · Cited by 3
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice
Sherwood, M. W., Piccini, J. P., Holmes, D. N., Pieper, K. S., Steinberg, B. A., Fonarow, G. C., Allen, L. A., Naccarelli, G. V., Kowey, P. R., Gersh, B. J., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008274 · Cited by 3
“A-PePSI LIGhT” Assessment Score to Predict Pressure Sore Impaired Healing Late Recurrence, Immobility, Greater Surface, Inhibited Thrombocytes
Anker, A. M., Ruewe, M., Prantl, L., Geis, S., Kehrer, A., Baringer, M., Schiltz, D., Zeman, F., Vykoukal, J., & Klein, S. M. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008766 · Cited by 3
Safety and Clinical Results of Continuous Low-Dose Aspirin in Microendoscopic Laminectomy
Tarukado, K., Ono, T., Doi, T., Harimaya, K., & Nakashima, Y. (2023) · Spine Surgery and Related Research · doi:10.22603/ssrr.2022-0224 · Cited by 3
Effectiveness of perioperative anticoagulation interruption without heparin bridging on thromboembolic events in patients with atrial fibrillation undergoing elective invasive procedures: a systematic review protocol
Kaur, J., Thomas, L., Bhat, A., & Barker, T. H. (2023) · JBI Evidence Synthesis · doi:10.11124/jbies-22-00423 · Cited by 3
Reducing bleeding risk in patients on oral anticoagulation therapy
Soler‐Espejo, E., Esteve‐Pastor, M. A., Rivera‐Caravaca, J. M., Roldán, V., & Marín, F. R. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2275662 · Cited by 3
“While the use of LMWH as bridging therapy theoretically reduces the risk of thrombosis during the perioperative period, it also significantly increases the risk of bleeding during this same period [114].”
BackgroundInfluential
Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging
Caterina, R. D., Cate, H. T., & Pengo, V. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae615 · Cited by 3
Perioperative Antithrombotic Strategies in Vascular Surgery: A Survey in Germany
Dovzhanskiy, D. I., Bischoff, M. S., Passek, K., Böhner, H., & Böckler, D. (2025) · Health Science Reports · doi:10.1002/hsr2.70732 · Cited by 3
Use of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft
Liu, M., Aguele, C., & Darr, U. M. (2017) · Clinical Case Reports · doi:10.1002/ccr3.790 · Cited by 3
“Over 40% of patients being treated with oral anticoagulation are prescribed a direct oral anticoagulants (DOACs) according to a recent study assessing prescribing patterns [1].”
Background
Sobreutilización innecesaria. Estudio de los «no hacer» en pacientes con fibrilación auricular
Ortiz, M., Llamas, P., Sanmartı́n, M., Egido, J. A., del Toro, J., Egocheaga, M. I., Estévez, M., Navarro, I. M., & Mira, J. J. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2017.02.014 · Cited by 3
The year in cardiology 2017: arrhythmias and cardiac devices
Linde, C. M., & Steffel, J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx765 · Cited by 3
Venous thromboembolism prophylaxis and the impact of a thrombosis service at a Canadian level 1 trauma centre
Engels, P. T., Thomas, H., Coates, A. J., Bakry, H., Alali, A., AlGhambdi, A., Aljabri, A. M., & Bugshan, A. (2019) · Canadian Journal of Surgery · doi:10.1503/cjs.012918 · Cited by 3
Consenso colombiano de cuidados perioperatorios en cirugía cardiaca del paciente adulto
Mendoza, J. L., Atehortua, L. H., Estrada, V. H. N., Carlos Eduardo Rebolledo, M., Pérez, J. C. D., Sénior, J. M., Hernández-Leiva, E., Valencia, A. A., Escobar-Serna, J. F., Castell, C. R. D., et al. (2020) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2020.03.002 · Cited by 4
Iatrogenic Retinal Penetration from Intravitreal Injections
Kishore, K., McGowan, D. S., & Hanebrink, K. A. (2021) · Case Reports in Ophthalmology · doi:10.1159/000512695 · Cited by 3
Anticoagulation in special patient populations with atrial fibrillation
Ueberham, L., & Hindricks, G. (2021) · Herz · doi:10.1007/s00059-021-05042-1 · Cited by 4
Warfarin
Hadlock, G. C., Burnett, A., & Nutescu, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-73709-6_2 · Cited by 3
Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists
Robert, P., Akodad, M., Lattuca, B., Gandet, T., Macia, J., Schmutz, L., Delseny, D., Piot, C. A., Leclercq, F., & Cayla, G. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30248 · Cited by 3
“As all our study patients had anticoagulant therapy, comparison with bleeding events observed in all comers registries must be done with caution.(12,15) TABLE 1 Baseline characteristics of the overall population (n = 88)”
Background
Is emergency gastrointestinal system tumour surgery safe under treatment of antitrombotics?
İlhan, M. (2022) · Turkish Journal of Trauma and Emergency Surgery · doi:10.14744/tjtes.2022.92442 · Cited by 3
“Some authors recommend bridging anticoagulation therapy with LMWH for the majority of patients who need to discontinue Coumadin therapy.[3,13] Other investigators argued that the risk of thromboembolism during discontinuation of Coumadin treatment was exaggerated and was higher than the risk of postoperative bleeding…”
Background
1821–2021: Contributions of physicians and researchers of Greek descent in the advancement of clinical and experimental cardiology and cardiac surgery
Gerontas, A. K., Avgerinos, D. V., Charitakis, K., Maragou, H., & Drosatos, K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1231762 · Cited by 3
“He was one of the leading investigators in a landmark clinical trial (49), which proved that a no-heparin bridging approach in perioperative settings is safer and as efficacious as a bridging approach, thus simplifying perioperative care globally.”
Perioperative Optimization and Management of the Oral and Maxillofacial Surgical Patient: A Narrative Review on Updates in Anticoagulation, Hypertension and Diabetes Medications
Allyn, S., Bentov, N., & Dillon, J. K. (2023) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2023.11.015 · Cited by 3
Potential of Direct Oral Anticoagulant in Bleeding After Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis
Higuchi, K., Goto, O., Matsuda, A., Nakagome, S., Habu, T., Ishikawa, Y., Koizumi, E., Kirita, K., Noda, H., Onda, T., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08271-6 · Cited by 3
“…a total of 1884 patients that had received warfarin for non-valvular atrial fibrillation in the perioperative period reported that no bridging was not inferior to dalteparin bridging therapy with regard to the incidence of thromboembolic events and decreased the risk of major bleeding [27].”
Patient blood management in major digestive surgery: Recommendations from the Italian multisociety (ACOI, SIAARTI, SIdEM, and SIMTI) modified Delphi consensus conference
Catarci, M., Tritapepe, L., Rondinelli, M. B., Beverina, I., Agostini, V. W., Buscemi, F., Amisano, M. F., Attinà, G. M., Baldini, G., Cerutti, A., et al. (2024) · Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons · doi:10.1097/ia9.0000000000000041 · Cited by 3
Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial
Douketis, J. D., Yi, Q., Bhatt, D. L., Muehlhofer, E., Wang, M. K., Connolly, S. J., Yusuf, S., Maggioni, A. P., & Eikelboom, J. W. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.03.030 · Cited by 3
Perioperative Management of Antiplatelet and Anticoagulation in Brain Tumor Surgery: A Survey of International Practices
Bailey, D., Wilding, H. E., Ganesalingam, N., & Rizk, E. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.07.111 · Cited by 3
Use of Prophylactic or Therapeutic Anticoagulation in Critically Ill Patients With Pre-existing Atrial Fibrillation
Chilbert, M. R., Gressel, L., Lee, L., Kersten, B. P., Zammit, K., & Woodruff, A. E. (2024) · Hospital Pharmacy · doi:10.1177/00185787241295997 · Cited by 3
“14,15 In the BRIDGE trial, those who did not use parenteral anticoagulation bridging surrounding a procedure compared to bridging anticoagulation had a non-inferior rate of stroke and higher risk of major bleeding.”
Continued Versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation: A Meta-Analysis
Jain, H., Patel, N., Tariq, M. D., Al‐Shammari, A. S., Khan, R., Jain, J., Patel, R., Ahmed, F., Ahmed, R., & Alexander, T. J. (2025) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001979 · Cited by 3
Konsensuspapier: Schlaganfallprophylaxe bei Patienten mit nichtvalvulärem Vorhofflimmern
Helms, T. M., Silber, S., Schäfer, A., Masuhr, F., Palm, F., Darius, H., Schrör, K., Bänsch, D., Bramlage, P., Hankowitz, J., et al. (2016) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-016-0447-1 · Cited by 3
Periprocedural management of patients receiving novel oral anticoagulants
Pou, P. A., González, A. D., Martínez, L. J. P., Latorre, A. D., & Serrano-Alonso, M. (2017) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2016-001088 · Cited by 3
Insight into the perioperative management of direct oral anticoagulants: concerns and considerations
Ibrahim, A., Walsh, L., Algaali, M., Satti, Z., Kiernan, T. J., & Yan, B. P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1551879 · Cited by 3
Utilization of apixaban anti-Xa levels in transition from apixaban to warfarin in a patient with chronic renal dysfunction
Elgersma, B. M., & Zochert, S. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab469 · Cited by 3
“It may be reasonable to forego parenteral bridging therapy in patients with low thrombosis risk (ie, historical DVT many years ago and a, low CHA 2 DS 2 -VASC score).(25,26) Alternatively, bridging therapy could be delayed until the apixaban levels drop below 50 ng/mL, for low-thrombosisrisk patients, or for patients…”
Background
Gastrointestinale Blutungen
Götz, M. (2018) · Die Gastroenterologie · doi:10.1007/s11377-018-0285-2 · Cited by 3
“Eine überbrückende Therapie perioperativ mit niedermolekularen Heparinen bei Vorhofflimmern wird nicht mehr empfohlen, da dieses „bridging“ mit einer erhöhten Blutungsrate bei nicht unterschiedlicher Ischämierate vergesellschaftet ist [11].”
Effects of peri-operative bridging with low molecular weight heparins on coagulation during interruption of vitamin K antagonists: A mechanistic study
Eijgenraam, P., Cate, H. T., Henskens, Y., van den Ham, R., & ten Cate‐Hoek, A. J. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.02.019 · Cited by 3
The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
Kuznetsov, S., Barcelona, R., Josephson, R., & Mohan, S. K. M. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0645-6 · Cited by 3
Infarctus rénal bilatéral à l’arrêt d’un traitement anticoagulant
Lavoignet, C.-É., Borgne, P. L., Ugé, S., Veneziano, R., Brunhuber, C., Kam, C., & Bilbault, P. (2016) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2016.01.014 · Cited by 3
Update in perioperative cardiac medicine
Cohn, S. L., Dutta, S., Slawski, B. A., Grant, P., & Smetana, G. W. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.16076 · Cited by 3
Triple Antithrombotic Therapy and Outcomes in Post‐PCI Patients Undergoing Non‐cardiac Surgery
Valle, J. A., Graham, L. A., DeRussy, A. J., Itani, K. M. F., Hawn, M. T., & Maddox, T. M. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3725-5 · Cited by 3
Unnecessary overuse. Study of “inadvisable practices” for patients with atrial fibrillation
Ortiz, M., Llamas, P., Sanmartı́n, M., Egido, J. A., del Toro, J., Egocheaga, M. I., Estévez, M., Navarro, I. M., & Mira, J. J. (2017) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2017.02.003 · Cited by 3
Outpatient Oral Anticoagulant Therapy
Ansell, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00037-6 · Cited by 3
Review of the top 5 cardiology studies of 2015-16
Barry, A. R., Babadagli, H. E., Basaraba, J. E., Boswell, R., Chen, J. W., Omar, M. A., Pollmann, D. M., Zhou, J. S., & Ackman, M. L. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517729835 · Cited by 3
Management of Patients Using Oral Anticoagulant Agent in Dental Practice
Doğanay, Ö., Yücesoy, T., & Alkan, A. (2019) · Bezmialem Science · doi:10.14235/bas.galenos.2018.2199 · Cited by 3
“(8) stopped warfarin in patients with AF with low risk of thromboembolism and treated one group with placebo and treated other group with 100 IU/kg dalteparin bridging treatment.”
BackgroundMethod
Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma
Sorigué, M., & Kuittinen, O. M. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1943351 · Cited by 4
Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry
Hata, R., Yamashita, Y., Morimoto, T., Kadota, K., Amano, H., Murai, R., Osakada, K., Sano, A., Takase, T., Hiramori, S., et al. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02564-7 · Cited by 3
“Invasive procedures were classified into two categories; low and high bleeding-risk categories, which were defined as per previously published classification [8].”
MethodResult
Impact of perioperative antithrombotic strategies on clinical events in non-cardiac surgery
Saito, K., Saito, Y., Muramatsu, T., Kitahara, H., Fujimoto, Y., Isono, S., & Kobayashi, Y. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02044-9 · Cited by 3
Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso multidisciplinar
Ferrandis, R., & Llau, J. V. (2018) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2018.05.002 · Cited by 3
Approaching a Safe Last Resort
Beattie, W. S., & Wijeysundera, D. N. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001161 · Cited by 3
Correction to: Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study
Unverdorben, M., von Heymann, C., Santamaría, A., Saxena, M., Vanassche, T., Jin, J., Laeis, P., Wilkins, R., Chen, C., & Colonna, P. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01873-2 · Cited by 3
Perioperative Care of Heart Failure, Arrhythmias, and Valvular Heart Disease
O’Glasser, A. Y., & Manjarrez, E. C. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.05.001 · Cited by 2
The rate of postoperative hematoma following risk-adapted cessation of oral anticoagulation in patients undergoing endoscopic endonasal surgery for pituitary adenomas
Löschner, D., Enciu, A., Wagle, P. R., Jung, A., Kellner, G., Meyer, A., & Gerlach, R. (2024) · Acta Neurochirurgica · doi:10.1007/s00701-024-06387-2 · Cited by 2
“The hallmark BRIDGE study [14] provided class I evidence, that a simple interruption of warfarin in the average AF patient undergoing an elective procedure or surgery is noninferior to bridging therapy in terms of efficacy and superior to bridging therapy in preventing major bleeding.”
Influential
Iron deficiency anemia and uterine disorders: Impact on surgical management
Arab, H., Bukhari, M. E., Alkhamis, W. H., Al-Badawi, I. A., Shukri, M. N. A., Angioni, S. L., Chahine, R., Vannuccini, S., & Chapron, C. (2025) · Journal of Endometriosis and Uterine Disorders · doi:10.1016/j.jeud.2025.100112 · Cited by 2
Perioperative Management of Oral Anticoagulation in Patients with Venous Thromboembolism
Sherwood, J. R., Parsons, A. J., Jammala, H. A., & Kaatz, S. S. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.03.005 · Cited by 2
Abordaje del tratamiento antitrombótico durante el perioperatorio y el periprocedimiento: documento de consenso 2025 de SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT y AEU
Vivas, D., Ferrandis, R., Anguita-Sánchez, M. P., Gámez, M. A., Arcelus, J. I., Echeverri, M., Egocheaga, I., Esteve‐Pastor, M. A., Ferreiro, J. L., Llau, J. V., et al. (2025) · Revista Española de Cardiología · doi:10.1016/j.recesp.2025.07.008 · Cited by 2
Chronic anticoagulation therapy associated with increased complications following hemiarthroplasty in hip fracture patients
Shabani, S., Wier, J. R., Mulakaluri, A., McCavitt, D. G., Duong, A., Firoozabadi, R., & Patterson, J. T. (2025) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-025-04578-w · Cited by 2
“This investigation determined that risks of bleeding outweighed risks of thrombotic complications for patients bridged with heparin during perioperative warfarin discontinuation [31] .”
Peri-procedural anticoagulation management for central venous catheter insertion in persons with cancer
Abdulrehman, J., Shaw, J. R., Stella, S. F., Mafeld, S. C., Douketis, J., Selby, R., Gross, P., & Carrier, M. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109620 · Cited by 2
Optimal Timing of Resuming Anticoagulant After Colorectal Endoscopic Submucosal Dissection
Togo, D., Yoshida, N., Hayashi, Y., Takada, K., Oka, S., Fukunaga, S., Morita, Y., Hayashi, T., Kozuka, K., Tsuji, Y., et al. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70370 · Cited by 2
CAR/CAIR Practice Guidelines: Periprocedural Management of Patient Bleeding Risk
Harper, K. C., Hurrell, C., Gupta, A., Parab, R., Boucher, L.-M., Pai, M., Selby, R., Callum, J., & Ménard, A. (2026) · Canadian Association of Radiologists Journal · doi:10.1177/08465371261433905 · Cited by 2
Prescribing Caution: A Critique of OpenEvidence to Answer Medication‐Related Questions
Bergsbaken, J. M., Wilson, P., Vandagriff, S., Christensen, L., & Vellardita, L. (2026) · JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70237 · Cited by 2
2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001472 · Cited by 2
Managing Anticoagulation in Patients Receiving Implantable Cardiac Devices
Chousou, P. A., & Pugh, P. J. (2017) · Future Cardiology · doi:10.2217/fca-2017-0044 · Cited by 2
Uso de la anticoagulación oral en el paciente sometido a un procedimiento invasivo
Fuentes, D. S., Sánchez, M. A. B., & Sánchez, M. P. L. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.06.003 · Cited by 2
Preoperative Patient Evaluation for Anesthesia Care Outside of the Operating Room
Beg, Y., & Sweitzer, B. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780190495756.003.0002 · Cited by 2
Contemporary trends in stroke complicating cardiac catheterisation
Whitehead, N., Williams, T. D., Brienesse, S. C., Ferreira, D., Murray, N., Inder, K., Beautement, S., Spratt, N. J., Boyle, A., & Collins, N. J. (2019) · Internal Medicine Journal · doi:10.1111/imj.14405 · Cited by 2
Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
Pal, P., Tandan, M., & Reddy, D. N. (2019) · Journal of Digestive Endoscopy · doi:10.4103/jde.jde_10_19 · Cited by 2
Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
van Til, J. A., Oudshoorn-Groothuis, C., Weernink, M. G. M., & von Birgelen, C. (2020) · Patient · doi:10.1007/s40271-020-00420-z · Cited by 2
“Bridging was omitted, because a trial demonstrated that not using bridging anti-coagulation was non-inferior to perioperative bridging [15].”
Method
Interruption of anticoagulation in patients undergoing elective surgical procedures
Łętek, A., Zandecki, Ł., Janion−Sadowska, A., & Polewczyk, A. (2020) · Medical Studies · doi:10.5114/ms.2020.94089 · Cited by 2
“This practice is supported by the BRIDGE trial, which randomly assigned 1884 patients with atrial fibrillation, who required interruption of warfarin for an invasive procedure to receive bridging anticoagulation with the LMW heparin (dalteparin) versus placebo [13].”
BackgroundMethod
Management of antithrombotics for intramuscular injection of botulinum toxin for spasticity. A survey of real-life practice in France
Ble, O., Bensmaïl, D., Pérennou, D. A., Parratte, B., Joseph, P., Boyer, F. C., Michelon, H., Lansaman, T., & Lévy, J. (2021) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2020.101467 · Cited by 2
Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study
Eljilany, I., Elarref, M., Shallik, N. A., Elzouki, A.-N. Y., Mohammed, A., Shoman, B., Ibrahim, S. M., Carr, C. S., Al‐Badriyeh, D., Cavallari, L. H., et al. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100816 · Cited by 2
Perioperative Assessment and Optimization in Major Colorectal Surgery: Medication Management
Kane, W. J., & Berry, P. S. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1761156 · Cited by 2
Potential for a Virtual Care Model in the Perioperative Management of Anticoagulant Therapy: A 5-Year Retrospective Clinic Review
Douketis, J. D., & Schulman, S. (2023) · TH Open · doi:10.1055/a-2098-6782 · Cited by 2
Stroke risk related to intentional discontinuation of antithrombotic therapy for invasive procedures
Mitsui, N., Kinoshita, M., Sawada, J., Fujiya, M., & Furukawa, H. (2023) · Neurosurgical FOCUS · doi:10.3171/2023.7.focus23341 · Cited by 2
Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial
Wang, B., Su, Y., Ma, C., Xu, L., Mao, Q., Cheng, W., Lu, Q., Zhang, Y., Wang, R., Lü, Y., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03391-2 · Cited by 2
“Randomized controlled trials comparing the use of bridging therapy with no bridging therapy in patients with atrial fibrillation have shown a higher bleeding risk without a change in the incidence of thromboembolic events [15, 16].”
Background
Exploring the Perioperative Use of DOACs, off the Beaten Track
Lucà, F., Oliva, F. G., Giubilato, S., Abrignani, M. G., Rao, C. M., Cornara, S., Caretta, G., Fusco, S. A. D., Ceravolo, R., Parrini, I., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113076 · Cited by 3
Thrombotic events in patients underwent simultaneous bilateral total knee arthroplasty with modern perioperative blood management strategy
Tsukada, S., Saito, M., Ogawa, H., Nishino, M., & Hirasawa, N. (2024) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-024-05624-8 · Cited by 2
The effect of anticoagulation therapy on the surgical outcomes of minimally invasive major gastrointestinal surgery
Harada, K., Uemoto, Y., Nagata, K., Matsuoka, T., Yamana, I., Watanabe, T., Kawamura, Y., & Fujikawa, T. (2024) · Surgical Endoscopy · doi:10.1007/s00464-024-11465-8 · Cited by 2
Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspective
Airaksinen, J. K. E., Langén, V. L., Teppo, K., & Lip, G. Y. H. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.14390 · Cited by 2
Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
Chen, B., Phan, M. T., Pasupuleti, V., Roman, Y. M., & Hernández, A. V. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013816.pub2 · Cited by 2
Peri-Procedural Outcomes of Left Atrial Appendage Occlusion in Lower Versus Higher CHA2DS2-VASc Score
Feroze, R. A., Saeed, Y., Ullah, W., Alhabdan, N. A., Cove, A., Frazzetto, M., Tashtish, N., Dallan, L. A. O., & Filby, S. J. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.01.033 · Cited by 2
Cangrelor, a newer P2Y12 inhibitor, in neuro-interventional procedures: a systematic review and updated meta-analysis
Gonçalves, O. R., Santos, A. B., Hong, A., Cardoso, L. J. C., Ferreira, M. Y., Fukunaga, C. K., Ohannesian, V. A., Almeida, K. J., & Ribeiro, F. V. (2025) · Neuroradiology · doi:10.1007/s00234-025-03573-6 · Cited by 2
“The swift reversal of P2Y12 inhibition provided by cangrelor could mitigate intraoperative bleeding and reduce the likelihood of subsequent hemorrhagic events [30]. completing the reperfusion process, which is consistent with previous reports [6, 15, 20, 24, 25].”
Impact of a novel protocol for atrial fibrillation management in outpatient gastrointestinal endoscopic procedures: a retrospective cohort study
Longino, J., Chaddha, A., Kalscheur, M. M., Rikkers, A. M., Gopal, D. V., Field, M. E., & Wright, J. M. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0915-0 · Cited by 2
Bridging Anticoagulation Therapy
Kulkarni, S. A., & Fang, M. C. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5934 · Cited by 2
Management of Common Cardiovascular Emergencies in Critically Ill Patients
Mantha, Y., Harada, R., & Hieda, M. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.11.001 · Cited by 2
Platelet Inhibition and Anticoagulation in Visceral Interventions
Fischbach, W. (2020) · Visceral Medicine · doi:10.1159/000508580 · Cited by 2
Anticoagulation Management in Geriatric Orthopedic Trauma Patients
Morris, J. C., & O’Connor, M. I. (2020) · Current Geriatrics Reports · doi:10.1007/s13670-020-00345-3 · Cited by 2
“There was, however, a more than 2-fold increase in incidence of major bleeding [24].”
Background
Perioperative management of vitamin K antagonists in patients with low thromboembolic risk undergoing elective surgery: A prospective experience
Becerra, A. F., Cornavaca, M. T., Revigliono, J. I., Contreras, A., Albertini, R. A., & Tabares, A. H. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.07.012 · Cited by 2
Периоперационный менеджмент антитромботических препаратов
Тарасенко, С. О., Дубров, С. О., Suslov, G., & Мазніченко, В. А. (2021) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.16.7-8.2020.223710 · Cited by 2
Upper Gastrointestinal Bleeding
Costable, N. J., & Greenwald, D. A. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_47-1 · Cited by 2
Chronisch kranke Menschen
Jobst, D., Mücke, M., & Weckbecker, K. (2023) · Elsevier eBooks · doi:10.1016/b978-3-437-23327-2.00022-3 · Cited by 2
Reversal of direct oral anticoagulants in hemophilia treatment
Feistritzer, C., & Schmidt, S. U. (2016) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-016-0284-2 · Cited by 2
Massive Preperitoneal Hematoma after a Subcutaneous Injection
Katagiri, H., Yoshikawa, K., Lefor, A. K., Kubota, T., & Mizokami, K. (2016) · Case Reports in Surgery · doi:10.1155/2016/7013708 · Cited by 2
“clearly defined [6], close monitoring and adjustment of aPTT are required when necessary.”
Background
Heparinas de bajo peso molecular en pacientes con fibrilación auricular
Romero, J. M. C. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.09.007 · Cited by 2

Authors: Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., Schulman, S., Turpie, A. G. G., Hasselblad, V., & Ortel, T. L.
Affiliations: Rush University Medical Center (US)
Northwell Health (US)
Hurley Medical Center (US)
University of Cincinnati (US)
Endeavor Health (US)
University of Washington Medical Center (US)
Duke Medical Center (US)
McMaster University (CA)
ORCID: Douketis, James D.
Spyropoulos, Alex C.
Kaatz, Scott
Becker, Richard C.
Dunn, Andrew S.
Garcia, David A.
Jaffer, Amir K.
Schulman, Sam
Ortel, Thomas L.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-08-27
Volume: 373
Issue: 9
Pages: 823-833
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1501035
PMC: PMC4931686
OpenAlex: W1837600385
Cited by: 1,184
References: 46
Citations by year: 2026: 63 · 2025: 64 · 2024: 79 · 2023: 70 · 2022: 87 · 2021: 115 · 2020: 132 · 2019: 117 · 2018: 134 · 2017: 141 · 2016: 141 · 2015: 35
FWCI: 109.42
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (U01HL086755, U01HL087229)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: atrial fibrillation, low molecular weight heparin, dalteparin, warfarin interruption, arterial thromboembolism, major bleeding, elective surgery, non-inferiority, stroke prevention, systemic embolism, transient ischemic attack, postoperative bleeding risk
MeSH terms: Adult, Anticoagulants, Atrial Fibrillation, Double-Blind Method, Female, Hemorrhage, Heparin, Low-Molecular-Weight, Humans, Male, Postoperative Complications, Thromboembolism, Warfarin, Elective Surgical Procedures, Perioperative Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks